Financhill
Sell
22

CUTRQ Quote, Financials, Valuation and Earnings

Last price:
$0.00
Seasonality move :
-7.56%
Day range:
$0.02 - $0.03
52-week range:
$0.02 - $3.00
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.00x
P/B ratio:
--
Volume:
2.8M
Avg. volume:
13.6M
1-year change:
-98.89%
Market cap:
$438K
Revenue:
--
EPS (TTM):
--

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
CUTRQ
Cutera
-- -- -- -- --
AXGN
Axogen
$53.4M $0.08 17.91% -76% $25.00
ELMD
Electromed
$16.6M -- 13.91% -- $37.00
IRIX
IRIDEX
$12.8M -$0.12 -2.72% -18.18% --
MYO
Myomo
$11.4M -$0.06 147.75% -20% $8.85
STXS
Stereotaxis
$7.7M -$0.07 -0.07% -20.83% $4.50
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
CUTRQ
Cutera
$0.02 -- $438K -- $0.00 0% 0.00x
AXGN
Axogen
$17.27 $25.00 $765.8M -- $0.00 0% 4.08x
ELMD
Electromed
$24.62 $37.00 $210.7M 32.83x $0.00 0% 3.70x
IRIX
IRIDEX
$1.13 -- $18.8M -- $0.00 0% 0.38x
MYO
Myomo
$5.19 $8.85 $178.4M -- $0.00 0% 6.02x
STXS
Stereotaxis
$1.83 $4.50 $156.1M -- $0.00 0% 5.79x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
CUTRQ
Cutera
-- -3.861 -- --
AXGN
Axogen
31.37% 0.673 6.53% 1.88x
ELMD
Electromed
-- 1.614 -- 4.68x
IRIX
IRIDEX
51.25% 1.329 9.47% 0.73x
MYO
Myomo
-- 2.236 -- 2.82x
STXS
Stereotaxis
-- 1.401 -- 0.74x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
CUTRQ
Cutera
-- -- -- -- -- --
AXGN
Axogen
$37.6M $2M -6.89% -10.21% 4.56% $7.9M
ELMD
Electromed
$12.6M $2.5M 15.91% 15.91% 15.64% $2.9M
IRIX
IRIDEX
$4.3M -$1.9M -146.36% -157.91% -16.15% -$3.1M
MYO
Myomo
$8.6M -$245.3K -48.64% -48.64% -2.03% $2.5M
STXS
Stereotaxis
$3.2M -$7.6M -139.2% -139.2% -120.3% -$4.3M

Cutera vs. Competitors

  • Which has Higher Returns CUTRQ or AXGN?

    Axogen has a net margin of -- compared to Cutera's net margin of 0.91%. Cutera's return on equity of -- beat Axogen's return on equity of -10.21%.

    Company Gross Margin Earnings Per Share Invested Capital
    CUTRQ
    Cutera
    -- -- --
    AXGN
    Axogen
    76.06% $0.01 $151.4M
  • What do Analysts Say About CUTRQ or AXGN?

    Cutera has a consensus price target of --, signalling upside risk potential of 9116.59%. On the other hand Axogen has an analysts' consensus of $25.00 which suggests that it could grow by 44.76%. Given that Cutera has higher upside potential than Axogen, analysts believe Cutera is more attractive than Axogen.

    Company Buy Ratings Hold Ratings Sell Ratings
    CUTRQ
    Cutera
    0 0 0
    AXGN
    Axogen
    4 0 0
  • Is CUTRQ or AXGN More Risky?

    Cutera has a beta of 1.358, which suggesting that the stock is 35.755% more volatile than S&P 500. In comparison Axogen has a beta of 1.024, suggesting its more volatile than the S&P 500 by 2.388%.

  • Which is a Better Dividend Stock CUTRQ or AXGN?

    Cutera has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Axogen offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cutera pays -- of its earnings as a dividend. Axogen pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CUTRQ or AXGN?

    Cutera quarterly revenues are --, which are smaller than Axogen quarterly revenues of $49.4M. Cutera's net income of -- is lower than Axogen's net income of $450K. Notably, Cutera's price-to-earnings ratio is -- while Axogen's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cutera is 0.00x versus 4.08x for Axogen. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CUTRQ
    Cutera
    0.00x -- -- --
    AXGN
    Axogen
    4.08x -- $49.4M $450K
  • Which has Higher Returns CUTRQ or ELMD?

    Electromed has a net margin of -- compared to Cutera's net margin of 12.11%. Cutera's return on equity of -- beat Electromed's return on equity of 15.91%.

    Company Gross Margin Earnings Per Share Invested Capital
    CUTRQ
    Cutera
    -- -- --
    ELMD
    Electromed
    77.68% $0.22 $43.6M
  • What do Analysts Say About CUTRQ or ELMD?

    Cutera has a consensus price target of --, signalling upside risk potential of 9116.59%. On the other hand Electromed has an analysts' consensus of $37.00 which suggests that it could grow by 50.28%. Given that Cutera has higher upside potential than Electromed, analysts believe Cutera is more attractive than Electromed.

    Company Buy Ratings Hold Ratings Sell Ratings
    CUTRQ
    Cutera
    0 0 0
    ELMD
    Electromed
    2 0 0
  • Is CUTRQ or ELMD More Risky?

    Cutera has a beta of 1.358, which suggesting that the stock is 35.755% more volatile than S&P 500. In comparison Electromed has a beta of 0.413, suggesting its less volatile than the S&P 500 by 58.696%.

  • Which is a Better Dividend Stock CUTRQ or ELMD?

    Cutera has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Electromed offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cutera pays -- of its earnings as a dividend. Electromed pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CUTRQ or ELMD?

    Cutera quarterly revenues are --, which are smaller than Electromed quarterly revenues of $16.3M. Cutera's net income of -- is lower than Electromed's net income of $2M. Notably, Cutera's price-to-earnings ratio is -- while Electromed's PE ratio is 32.83x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cutera is 0.00x versus 3.70x for Electromed. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CUTRQ
    Cutera
    0.00x -- -- --
    ELMD
    Electromed
    3.70x 32.83x $16.3M $2M
  • Which has Higher Returns CUTRQ or IRIX?

    IRIDEX has a net margin of -- compared to Cutera's net margin of -16.69%. Cutera's return on equity of -- beat IRIDEX's return on equity of -157.91%.

    Company Gross Margin Earnings Per Share Invested Capital
    CUTRQ
    Cutera
    -- -- --
    IRIX
    IRIDEX
    37.33% -$0.12 $5.4M
  • What do Analysts Say About CUTRQ or IRIX?

    Cutera has a consensus price target of --, signalling upside risk potential of 9116.59%. On the other hand IRIDEX has an analysts' consensus of -- which suggests that it could grow by 76.99%. Given that Cutera has higher upside potential than IRIDEX, analysts believe Cutera is more attractive than IRIDEX.

    Company Buy Ratings Hold Ratings Sell Ratings
    CUTRQ
    Cutera
    0 0 0
    IRIX
    IRIDEX
    0 0 0
  • Is CUTRQ or IRIX More Risky?

    Cutera has a beta of 1.358, which suggesting that the stock is 35.755% more volatile than S&P 500. In comparison IRIDEX has a beta of 0.936, suggesting its less volatile than the S&P 500 by 6.383%.

  • Which is a Better Dividend Stock CUTRQ or IRIX?

    Cutera has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. IRIDEX offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cutera pays -- of its earnings as a dividend. IRIDEX pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CUTRQ or IRIX?

    Cutera quarterly revenues are --, which are smaller than IRIDEX quarterly revenues of $11.6M. Cutera's net income of -- is lower than IRIDEX's net income of -$1.9M. Notably, Cutera's price-to-earnings ratio is -- while IRIDEX's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cutera is 0.00x versus 0.38x for IRIDEX. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CUTRQ
    Cutera
    0.00x -- -- --
    IRIX
    IRIDEX
    0.38x -- $11.6M -$1.9M
  • Which has Higher Returns CUTRQ or MYO?

    Myomo has a net margin of -- compared to Cutera's net margin of -2.16%. Cutera's return on equity of -- beat Myomo's return on equity of -48.64%.

    Company Gross Margin Earnings Per Share Invested Capital
    CUTRQ
    Cutera
    -- -- --
    MYO
    Myomo
    71.39% -$0.01 $24.7M
  • What do Analysts Say About CUTRQ or MYO?

    Cutera has a consensus price target of --, signalling upside risk potential of 9116.59%. On the other hand Myomo has an analysts' consensus of $8.85 which suggests that it could grow by 70.52%. Given that Cutera has higher upside potential than Myomo, analysts believe Cutera is more attractive than Myomo.

    Company Buy Ratings Hold Ratings Sell Ratings
    CUTRQ
    Cutera
    0 0 0
    MYO
    Myomo
    3 0 0
  • Is CUTRQ or MYO More Risky?

    Cutera has a beta of 1.358, which suggesting that the stock is 35.755% more volatile than S&P 500. In comparison Myomo has a beta of 1.609, suggesting its more volatile than the S&P 500 by 60.902%.

  • Which is a Better Dividend Stock CUTRQ or MYO?

    Cutera has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Myomo offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cutera pays -- of its earnings as a dividend. Myomo pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CUTRQ or MYO?

    Cutera quarterly revenues are --, which are smaller than Myomo quarterly revenues of $12.1M. Cutera's net income of -- is lower than Myomo's net income of -$260.1K. Notably, Cutera's price-to-earnings ratio is -- while Myomo's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cutera is 0.00x versus 6.02x for Myomo. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CUTRQ
    Cutera
    0.00x -- -- --
    MYO
    Myomo
    6.02x -- $12.1M -$260.1K
  • Which has Higher Returns CUTRQ or STXS?

    Stereotaxis has a net margin of -- compared to Cutera's net margin of -118.53%. Cutera's return on equity of -- beat Stereotaxis's return on equity of -139.2%.

    Company Gross Margin Earnings Per Share Invested Capital
    CUTRQ
    Cutera
    -- -- --
    STXS
    Stereotaxis
    50.73% -$0.09 $11.4M
  • What do Analysts Say About CUTRQ or STXS?

    Cutera has a consensus price target of --, signalling upside risk potential of 9116.59%. On the other hand Stereotaxis has an analysts' consensus of $4.50 which suggests that it could grow by 145.9%. Given that Cutera has higher upside potential than Stereotaxis, analysts believe Cutera is more attractive than Stereotaxis.

    Company Buy Ratings Hold Ratings Sell Ratings
    CUTRQ
    Cutera
    0 0 0
    STXS
    Stereotaxis
    2 0 0
  • Is CUTRQ or STXS More Risky?

    Cutera has a beta of 1.358, which suggesting that the stock is 35.755% more volatile than S&P 500. In comparison Stereotaxis has a beta of 1.546, suggesting its more volatile than the S&P 500 by 54.601%.

  • Which is a Better Dividend Stock CUTRQ or STXS?

    Cutera has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Stereotaxis offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Cutera pays -- of its earnings as a dividend. Stereotaxis pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios CUTRQ or STXS?

    Cutera quarterly revenues are --, which are smaller than Stereotaxis quarterly revenues of $6.3M. Cutera's net income of -- is lower than Stereotaxis's net income of -$7.5M. Notably, Cutera's price-to-earnings ratio is -- while Stereotaxis's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Cutera is 0.00x versus 5.79x for Stereotaxis. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    CUTRQ
    Cutera
    0.00x -- -- --
    STXS
    Stereotaxis
    5.79x -- $6.3M -$7.5M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Goldman Sachs Stock a Buy Sell or Hold?
Is Goldman Sachs Stock a Buy Sell or Hold?

When the Federal Reserve started hiking rates in 2022, banks’…

Is Reddit a Buy on the Dip?
Is Reddit a Buy on the Dip?

Reddit (NYSE:RDDT) share price has been on the proverbial ropes…

Qualcomm Stock: 5G Leader at a Bargain Price?
Qualcomm Stock: 5G Leader at a Bargain Price?

Chip giant QUALCOMM Incorporated (NASDAQ:QCOM) was the ultimate chip company…

Stock Ideas

Buy
52
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3T
P/E Ratio: 41x

Buy
51
Is MSFT Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 33x

Alerts

Buy
59
GRRR alert for Mar 15

Gorilla Technology Group [GRRR] is up 29.72% over the past day.

Sell
49
SMTC alert for Mar 15

Semtech [SMTC] is up 21.28% over the past day.

Buy
62
PLPC alert for Mar 15

Preformed Line Products [PLPC] is up 17.38% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock